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1. Introduction 
The mechanism of insulin action on such diverse 
cellular activities as membrane transport, lipolysis, 
glycolysis and protein metabolism is essentially 
unknown. Since the early observations that insulin 
can decrease the rise of the cyclic AMP level in adipose 
tissue [l-2] and in liver cells [3-4] due to sub- 
maximal concentrations of glucagon, there has been 
some effort to show a direct effect of insulin on the 
adenylate cyclase system. 
It has been reported from different laboratories 
that insulin inhibited the glucagon stimulated adenylate 
cyclase activity of liver cell membranes [5-61. This 
finding, however, could not be confirmed in several 
other laboratories [7-lo] thus leaving the issue 
controversial. 
The present work was aimed at reinvestigating the 
effect of insulin on the adenylate cyclase system of 
rat liver plasma membrane. 
2. Materials and methods 
2.1. Materials 
Crystallized insulin and glucagon as well as ATP, 
GTP, Gpp(NH)p, isoproterenol, creatine phosphate 
and creatine phosphokinase were purchased from 
Sigma (St. Louis, MO.). [o-32P]ATP (20 Ci/mmol), 
[8-14C]ATP (0.1 Ci/mmol) and cyclic [U-14C]AMP 
(15 Ci/mmol) were obtained from the Radiochemical 
Centre (Amersham). Neutral aluminiumoxid was 
bought from Merck. 
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2.2. Methods 
Liver plasma membranes were prepared from 
female PVC/c rats (6-8 weeks old) that had been 
starved overnight, according to the method of 
Neville [ 111. 
In typical experiments, the assay mixture for the 
measurement of adenylate cyclase activity contained 
0.5-1.0 mM [~x-~~P]ATP (lo-25 &i/pmol), 4 mM 
MgC12, 1 mM cyclic AMP, 25 mM creatine phosphate, 
60 pg creatine phosphokinase, 50 mM Tris-HCl 
pH 7.5 and 50-100 pug protein of liver plasma mem- 
brane in a final volume of 70 ~1. Incubations were 
terminated according to the method of White [ 121 
and cyclic AMP was separated by column chromatog- 
raphy on neutral alumina [ 121. Under these condi- 
tions, the formation of cyclic AMP was linear with 
time up to 10 min. 
Cyclic AMP dependent phosphodiesterase activity 
was measured in the above medium except that 
cyclic [U-14C]AMP was substituted for [cx-~~P] ATP. 
To measure the rate of ATP degradation (under the 
conditions of adenylate cyclase assay), [8-14C]ATP 
was used. 
ATP and its derivatives, including adenosine, were 
separated on polyethyleneimine impregnated cel- 
lulose plates (Merck) using 0.1 M LiCl as solvent. 
Protein was determined according to the method 
of Lowry et al. [ 131 using bovine serum albumin as 
standard. 
3. Results and discussion 
Under the conditions described in the legend to 
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Table 1 
Effect of insulin on adenylate cyclase activity of rat liver plasma membrane 
Effector pmol cyclic AMP/mg protein/IO mm 
None 
Fluoride 15 mM 
GTP 10.’ Xl 
Gpp(NH)p 1O-4 M 
lsoproterenol 10“ M 
Isoproterenol 10m5 M 
+ GTP 1O-5 M 
Glucagon 10m7 M 
Glucapon lOm6 M 
Insulin 
None 10-r’ M lo-“’ M 
196 ? 19 
1581 f 87 
542 + 18 
1349 * 17 
244+ 5 
731 * 23 
613 + 26 
985 f 17 
202 * 14 189+12 
1612 + 17 1636 * 76 
_ 514 * 23 
1336 + 14 1344 + 56 
_ 216 + 23 
702 f 7 648 * 27 
579 + 16 485 f 11 
951 * 13 980 f 28 
lO-9 M 10“ M 
209 f 12 219 + 14 
1603 +z 95 1696 r 78 
_ _ 
1346 ? 29 1276 f 78 
_ _ 
633 5 11 628? 9 
517 I13 532519 
926 t 14 910 + 29 
Assay mi\;ture m a final volume of 70 ~1 contained 1 mM (w~~P]ATP (10 /1Ci/qnol), 4 mM 
MgCl,. 50 mM Tris-HCl, pH 7.5, 1 mM cyclic AMP, 25 mM creatine phosphate, 60 fig creatine 
phosphokinase. 0.1’; albumin, 76681 pg of liver plasma membrane protein and other additions 
as indicated. Incubations were performed at 33°C for 10 min. Results are the mean ? SEM of 
two identically performed separate experiments, each assayed in triplicate 
table 1, insulin at low concentrations (10-9-10-10 M) 
inhibited the glucagon stimulated adenylate cyclase 
activity by about 20% if the concentration of the 
latter hormone was not higher than 10m7 M. In the 
presence of other activators, the activity of adenylate 
cyclase was less (with isoproterenol + GTP) or not 
(with fluoride, GTP or Gpp(NH)p) inhibited by 
insulin. 
The reason for the absence of insulin effect at 
10e6 M of glucagon, and for the lower inhibitory 
effect of 10e7 M of insulin is not clear. These aspects 
of insulin effect were observed by others too [5.6]. 
To determine the reproducibility of the results 
shown in table 1, several experiments were performed 
under varied conditions. As a rule it was found that 
after 5 min of incubation. insulin inhibited the 
( 1O-7 M) glucagon-stimulated adenylate cyclase 
activity only if the concentration of ATP was at least 
1 mM and the amount of membrane protein was 
around 100 pg (data not shown). At lower concentra- 
tions of ATP and membrane protein significantly 
longer incubation times than 5 min were required to 
observe significant insulin effect. These suggested 
some indirect effects of insulin that could be: (a) 
stimulation of ATP degradation; (b) stimulation of 
adenosine formation that in turn would inhibit 
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adenylate cyclase [ 141 ; or (c) stimulation of cyclic 
AMP dependent phosphodiesterase. Neither of these 
processes were however influenced by 1 0e9-1 0-l’ M 
of insulin. These observations suggested that the 
presence of an ATP metabolite was obligatory for the 
inhibitory effect of insulin. Adenosine was a possible 
candidate for such a role because it represented more 
than 95% of the total ATP loss: during 10 min of 
incubation about 15% of ATP was metabolized. 
corresponding to more than 0.1 mM of adenosine if 
1 mM ATP and 100 ng membane protein was used. 
Therefore the combined effects of insulin and 
adenosine were studied subsequently at relatively 
low concentrations of ATP and membrane protein. 
Adenosine, at the concentration of lOa M, itself 
inhibited the (10m7 M) glucagon-stimulated adenylate 
cyclase (table 2). In the presence of 10m9 M of insulin, 
however, the inhibition was significantly higher 
(P-CO.01) than by adenosine alone (table 2). In these 
experiments the concentration of adenosine, formed 
from ATP, was 2 X IO-’ M at the end of 5-min 
incubation. The absence of effect of insulin when 
adenosine was not added externally indicates that 
adenosine at lower concentrations is not effective to 
promote the inhibitory action of insulin. It should be 
mentioned that at present it is not possible to clearly 
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Table 2 
Combined effects of insulin and adenosine on the glucagon stimulated 
adenylate cyclase activrty 
Additions pmol cyclic AMP/mg protein/S min 
None Insulin (1 0m9 M) P 
-_ 
Glucagon lo-’ M 
Glucagon 10m7 M 
+ adenosine lo-“ M 
647 f 23 615+29 ns. 
515 f 13 381 + 36 <o 01 
Assay mixture (70 ~1) contained 0.4 mM [&*P]ATP (25 ~Ci/~mol). 4 mM 
MgCI,. 1 mM cyclic AMP, 25 mM creatinc phosphate, 60 ~.rg creatine phospho- 
kinase. 0.1% albumin, 50 mM Tris-HCl. pll 7.5, 58-66 ).q of plasma membrane 
protein and other additions as indicated. Incubations were performed at 33°C 
for 5 min. Results are the mean i SEM of five separate experiments (with the 
same plasma membrane preparation) each assayed in triphcate. The plasma mem- 
brane preparation was different from that used for table 1; n.s., not significant by 
Student’s t test 
distinguish whether the inhibition by adenosine is dis- 
sociated from its promoting effect on insulin action, 
or insulin merely sensitizes the cyclase system for 
adenosine. 
While adenosine inhibited all the stimulated forms 
of adenylate cyclase activity (table 3) the combined 
inhibitory effect of adenosine and insulin could be 
consistently observed only in the case of lo-’ M 
glucagon stimulated cyclase. The data presented in 
table 1 and tab!e 3 are highly comparable in that the 
inhibitory effect of insulin both alone (table 1) and in 
combination with adenosine (table 3) was the highest 
in the case of lo-’ M glucagon-stimulated adenylate 
cyclase. This provides evidence that adenosine is 
implicated in the inhibition of the glucagon-stimulated 
adenylate cyclase system by insulin. 
On the other hand, comparison of data in table 1 
and in table 3 indicates that adenosine may not play 
a role in the inhibition of (isoproterenol t GTP)- 
activated adenylate cyclase activity by insulin. The 
Table 3 
Combined effects of insulin and adenosine on different activated forms of adenylate cyclase 
Additions pmol cyclic AMP/mg protein/S min 
None Insulin Adenosme Insulin (10s9 M) + adenosine (10m4 M) 
(1O-9 M) (1O-4 M) 
None 
Fluoride 15 mM 
Gpp(NH)p 1O-4 M 
Isoproterenol 10e5 M 
+ GTP lo-’ M 
Glucagon lo-’ M 
Glucagon 1Om6 M 
174 r 11 
638 + 86 
176 + 78 
634 + 14 
665 + 4 
260 + 53 
170 ? 16 161 + 13 157 t 11 
664 f 64 1312?27 1235 f 38 
167 f 53 918 + 38 916? 8 
662 f 13 520 + 14 478 * 24 
649+11 577 i 31 409 f 29 
204 + 20 982 + 61 840 * 55 
Assay mixture in a final volume of 70 ~1 contained 0.4 mM [c~-~*P]ATP (25 nCi/pmol), 4 mM MgCl,, 1 mM 
cyclic AMP, 25 mM creatine phosphate, 60 pg creatine phosphokinase, 0.1X albumin, 50 mM Tris-HCl, 
pH 7.5,63 ).rg of plasma membrane protein and other additions as indicated. Incubations were performed at 
33°C for 5 min. Results are the mean f SEM of four incubations in one representative experiment. Plasma 
membrane preparation was the same that used for the experiment of table 2 
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small inhibitory effect of adenosine + insulin. seen in 
the presence of isoproterenol + GTP (table 3) did not 
prove to be significant in three other experiments 
(p>o.2). Thus it seems that time is the major factor 
in the inhibition of the (isoproterenol + GTP)- 
stimulated adenylate cyclase activity by insulin. 
The dependence of insulin effect on the presence 
of divalent cations was also tested. The combined 
inhibitory effect of adenosine and insulin on the 
( 10e7 M) glucagon-stimulated cyclase activity was not 
significantly influenced by changing the concentration 
of Mg2+ between 2-10 mM. On the other hand, when 
the plasma membranes were preincubated with EGTA 
for 5 min at room temperature, the inhibitory effect 
of lo4 M of adenosine was of the same extent as in 
previous experiments, however, insulin did not cause 
further inhibition (data not shown). This indicates 
that Ca”, bound to the plasma membrane, also plays 
role in the inhibitory effect of insulin. 
In summary, present results confirm those data 
[5-61 that demonstrated the inhibitory effect of 
insulin on the glucagon stimulated adenylate cyclase 
activity. Such inhibition proved to require the presence 
of both adenosine and Ca2’. These new findings can 
be important for further studies on the structural 
relationship between the insulin-receptor complex 
and the adenylate cyclase system. 
I am grateful to Dr M. Wollemann for valuable 
discussion of this study and to Mrs I. Kasza for 
skilled technical assistance. 
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